4//SEC Filing
Cannell Thomas R 4
Accession 0001485003-22-000020
CIK 0001485003other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:36 PM ET
Size
5.2 KB
Accession
0001485003-22-000020
Insider Transaction Report
Form 4
Sesen Bio, Inc.SESN
Cannell Thomas R
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-02-18+606,800→ 606,800 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") which shall vest annually in equal amounts over a four-year period following the grant date, so long as the reporting person remains employed by Sesen Bio, Inc.(the "Company"). Each RSU represents a contingent right to receive one share of the Company's common stock. Based on market analysis by Radford of public, pre-commercial and commercial biopharmaceutical companies, the compensation committee of the Company recommended to the Company's board of directors, and the board of directors approved, the grant to the reporting person.
Documents
Issuer
Sesen Bio, Inc.
CIK 0001485003
Entity typeother
Related Parties
1- filerCIK 0001637822
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:36 PM ET
- Size
- 5.2 KB